Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 93, Issue 1, 2005, Pages 1-13

  Shields Botella, J ^a   Chetrite, G ^b   Meschi, S ^a   Pasqualini, J R ^b  

^a Non Clin R and D Department   (Monaco)

^b Institut de Puericulture   (France)

Author keywords

Brest cancer; Estrogen biosynthesis; Nomegestrol; Progestins

Indexed keywords

ANDROSTENEDIONE; AROMATASE; ESTRADIOL; ESTROGEN SULFATASE; ESTRONE; GLYCOPROTEIN E1; NOMEGESTROL ACETATE; SEX HORMONE; SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

BREAST ADENOCARCINOMA; BREAST CANCER; CELL TRANSFORMATION; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN SYNTHESIS; HUMAN; INHIBITION KINETICS; MENOPAUSE; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 14644403655     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.11.004     Document Type: Review

References (111)

1. C.J. Gruber, W. Tschugguel, C. Schneeberger, and J.C. Huber Production and actions of estrogens N. Engl. J. Med. 346 2002 340 352
2. B.E. Henderson, and H.S. Fiegelson Hormonal carcinogenesis Carcinogenesis 21 2000 427 433
3. C.R. Jefcoate, J.G. Liehr, R.J. Santen, T.R. Sutter, J.D. Yager, W. Yue, S.J. Santner, R. Tekmal, L. Demers, R. Pauley, F. Naftolin, G. Mor, and L. Berstein Tissue specific synthesis and oxidative metabolism of estrogens J. Natl. Cancer Inst. Monogr. 27 2000 95 112
4. K. Mitrunen, and A. Hirvonen Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat. Res. 544 2003 9 41
5. A. Purohit, and J.R. Reed Regulation of estrogen synthesis in postmenopausal women Steroids 67 2002 979 983
6. Endogenous Hormones Breast Cancer Collaborative Group Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J. Natl. Cancer Inst. 95 2003 1218 1226
7. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
8. J. Eden Progestins and breast cancer Am. J. Obstet. Gynecol. 188 2003 1125 1131
9. C. Stahlberg, A.T. Pedersen, E. Lynge, and B. Ottesen Hormone replacement therapy and risk of breast cancer: the role of progestins Acta Obstet. Gynecol. Scand. 82 2003 335 344
10. Writing group for Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
11. R. Sitruk-Ware Progestogens in hormonal replacement therapy: new molecules, risks, and benefits Menopause 9 2002 6 15
12. R.K. Ross, A. Paganini-Hill, P.C. Wan, and M.C. Pike Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J. Natl. Cancer Inst. 92 2000 328 362
13. R. Garcia-Becerra, E. Borja-Cacho, A.J. Cooney, K.J. Jackson, A.E. Lemus, G. Perez-Palacio, and F. Larrea The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-α J. Steroid Biochem. Mol. Biol. 82 2002 333 341
14. F. Larrea, R. Garcia-Becerra, A.E. Lemus, G.A. Garcia, G. Perez-Palacios, K.J. Jackson, K.M. Coleman, R. Dace, C.L. Smith, and A.J. Cooney A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ERα Endocrinology 142 2001 3791 3799
15. R. Santillan, G. Perez-Palacios, M. Reyes, P. Damian-Matsumura, G.A. Garcia, I. Gillasca, and A.E. Lemus Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites Eur. J. Pharmacol. 417 2001 167 174
16. A.E. Lemus, R. Santillan, P. Damian-Matsumura, G.A. Garcia, I. Grillasca, and G. Perez-Palacios In vitro metabolism of gestodene in target organs: formation of A-ring reduced derivatives with oestrogenic activity Eur. J. Pharmacol. 417 2001 249 256
17. A.E. Lemus, V. Zaga, R. Santillán, G.A. García, I. Grillasca, P. Damián-Matsumura, K.J. Jackson, A.J. Cooney, F. Larrea, and G. Pérez-Palacios The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites J. Endocrinol. 165 2000 693 702
18. W.G. Schoonen, G.H. Deckers, M.E. de Gooijer, R. de Ries, and H.J. Kloosterboer Hormonal properties of norethisterone 7alpha-methyl-norethisterone and their derivatives J. Steroid Biochem. Mol. Biol. 74 2000 213 222
19. J.R. Pasqualini Synthesis and regulation of sex hormones in breast cancer tissue durind pre- and post-menopause J. Menopause S2 2001 10 13
20. J.R. Pasqualini, G. Chetrite, B.L. Nguyen, C. Maloche, L. Delalonde, M. Talbi, M.C. Feinstein, C. Blacker, J. Botella, and J. Paris Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence J. Steroid Biochem. Mol. Biol. 53 1995 407 412
21. G. Chetrite, J. Paris, J. Botella, and J.R. Pasqualini Effect of nomegestrol acetate on estrone-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer cells J. Steroid Biochem. Mol. Biol. 58 1996 525 531
22. G.S. Chetrite, J. Paris, J. Shields-Botella, J.C. Philippe, and J.R. Pasqualini effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependant MCF-7 and T47-D Breast cancer cells Anticancer Res. 23 2003 4652 4656
23. L.H. Quian, B. Yang, L. Cao, and Z.P. Gu Inhibitory effect of nomegestrol acetate on steroidogenesis of cultured granulosa cells from rat ovary in vitro Acta Pharmacol. Sin. 22 2001 40 44
24. J. Shields-Botella, I. Duc, E. Duranti, F. Puccio, P. Bonnet, R. Delansorne, and J. Paris An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells J. Steroid Biochem. Mol. Biol. 87 2003 111 122
25. D.A. Fischer (Ed.), The Quest Diagnostics Manual, Endocrinology, Test Selection and Interpretation, 2nd ed., 1998.
26. F. Labrie, A. Bélanger, V. Luu-The, C. Labrie, J. Simard, L. Cusana, J.-L. Gomeza, and B. Candasa DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging Steroids 63 1998 322 328
27. C.A. Lamar, J.F. Dorgan, C. Longcope, F.Z. Stanczyk, R.T. Falk, and H.E. Stephenson Jr. Serum sex hormones and breast cancer risk factors in postmenopausal women Cancer Epidemiol. Biomarkers Prev. 12 2003 380 383
28. M. Maggliolini, O. Donze, E. Jeannin, S. Ando, and D. Picard Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha Cancer Res. 59 1999 4864J 4869J
29. J. Adams, M. Garcia, and H. Rochefort Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells Cancer Res. 41 1981 4720 4726
30. J.R. Pasqualini, G. Chetrite, C. Blacker, M.C. Feinstein, L. Delalonde, M. Talbi, and C. Maloche Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients J. Clin. Endocrinol. Metab. 81 1996 1460 1464
31. J. Szymczak, A. Milewicz, J.H.H. Thijssen, M.A. Blankenstein, and J. Daroszewski Concentration of sex steroids in adipose tissue after menopause Steroids 63 1998 319 321
32. J.H.H. Thijssen, A.A.J. Van Landeghem, and J. Poortman Uptake and concentration of steroid hormones in mammary tissues Ann. N. Y. Acad. Sci. 464 1986 106 116
33. V.H.T. James, M.J. Reed, P.A. Beraneck, R.C. Bonney, D.L. Samuel, C.J. Newton, S. Franks, and M.W. Ghilchik Androgen and estrogen metabolism in breast cancer patients Ann. N. Y. Acad. Sci. 464 1986 117 125
34. G.S. Chetrite, J. Cortes-Prieto, J.C. Philippe, F. Wright, and J.R. Pasqualini Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J. Steroid Biochem. Mol. Biol. 72 2000 23 27
35. S.E. Hankinson, W.C. Willet, J.E. Manson, G.A. Colditz, D.J. Hunter, D. Spiegelman, R.L. Barbieri, and F.E. Speizer Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J. Natl. Cancer Inst. 90 1998 1292 1299
36. T. Suzuki, T. Nakata, Y. Miki, C. Kaneko, T. Moriya, T. Ishida, S. Akinaga, H. Hirakawa, M. Kimura, and H. Sasano Estrogen sulfotransferase steroid sulfatase in human breast carcinoma Cancer Res. 63 2003 2762 2770
37. S. Chen, T. Itoh, K. Wu, D. Zhou, and C. Yang Transcriptional regulation of aromatase expression in human breast tissue J. Steroid Biochem. Mol. Biol. 83 2003 93 99
38. W. Yue, L.M. Berstein, J.-P. Wang, G.M. Clark, C.J. Hamilton, L.M. Demers, and R.J. Santen The potential role of estrogen in aromatase regulation in the breast J. Steroid Biochem. Mol. Biol. 79 2001 157 164
39. E.R. Simpson, C. Clyne, C. Speed, G. Rubin, and S. Bulun Tissue-specific estrogen biosynthesis and metabolism Ann. N. Y. Acad. Sci. 949 2001 58 67
40. G.S. Chetrite, and J.R. Pasqualini The selective estrogen enzyme modulator (SEEM) in breast cancer J. Steroid Biochem. Mol. Biol. 76 2001 95 104
41. T. Suzuki, T. Moriya, T. Ishida, M. Kimura, N. Ohuchi, and H. Sasano In situ production of estrogens in human breast carcinoma Breast Cancer 9 2002 296 302
42. R.J. Santen, D. Leszczynski, N. Tilson-Mallet, P.D. Feil, C. Wright, and A. Manni Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways Ann. N. Y. Acad. Sci. 464 1986 126 137
43. W.R. Miller, P. Mullen, P. Sourdaine, C. Watson, J.M. Dixon, and J. Telford Regulation of aromatase activity within the breast J. Steroid Biochem. Mol. Biol. 61 1997 193 202
44. F. Labrie, V. Luu-The, C. Labrie, A. Bélanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone Endocr. Rev. 24 2003 152 182
45. I.E. Smith, and M. Dowsett Aromatase inhibitors in breast cancer N. Engl. J. Med. 348 2003 2431 2442
46. H. Sasano, A.R. Frost, R. Saitoh, N. Harada, M. Poutanen, R. Vihko, S.E. Bulun, S.G. Silverberg, and H. Nagura Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma J. Clin. Endocrinol. Metab. 81 1996 4042 4046
47. W.R. Miller Biology of aromatase inhibitors: pharmacology/endocrinology wihthin the breast Endocr. Relat. Cancer 6 1999 187 195
48. H.J. Smith, P.J. Nicholls, C. Simons, and R. Le Lain Inhibitors for steroidogenesis as agents for the treatment of hormone-dependent cancers Exp. Opin. Ther. Patents 11 2001 790 824
49. E. Perel, D. Daniilescu, L. Kharlip, M. Blackstein, and D.W. Killinger Steroid modulation of aromatase activity in human cultured breast carcinoma cells J. Steroid Biochem. 29 1988 393 399
50. D.W. Killinger, E. Perel, D. Daniilescu, L. Kharlip, and M. Blackstein Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation Steroids 50 1987 523 536
51. D.F. Covey, W.F. Hood, and P.C. McMullan Studies of the inactivation of human placental aromatase by 17 alpha-ethynyl-substituted 10 beta-hydroperoxy and related 19-nor steroids Biochem. Pharmacol. 35 1986 1671 1674
52. T. Satoh, S. Itoh, T. Seki, S. Itoh, N. Nomura, and I. Yoshizawa On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production J. Steroid Biochem. Mol. Biol. 82 2002 209 216
53. A. Purohit, L.C. Lai, A. Singh, N.G. Coldham, M.W. Ghilchik, M.J. Reed, and V.H. James The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumors J. Steroid Biochem. 34 1989 443 446
54. S. Xiu-Zhu, D. Zhou, and S. Chen Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D Cells J. Steroid Biochem. Mol. Biol. 63 1997 29 36
55. W. Yue, and A.M.H. Brodie Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture J. Steroid Biochem. Mol. Biol. 63 1997 317 328
56. J. Shields-Botella, P. Bonnet, I. Duc, E. Duranti, S. Meschi, S. Cardinali, P. Prouheze, A.M. Chaigneau, V. Duranti, S. Gribaudo, A. Rivière, L. Mengual, D. Carniato, L. Cecchet, J. Lafay, B. Rondot, J. Sandri, J.C. Pascal, and R. Delansorne In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity J. Steroid Biochem. Mol. Biol. 84 2003 327 335
57. J.R. Pasqualini, J. Cortes-Prieto, G. Chetrite, M. Talbi, and A. Ruiz Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma Int. J. Cancer 70 1997 639 643
58. F.G. Hernandez-Guzman, T. Higashiyama, Y. Osawa, and D. Ghosh Purification, characterization and crystallization of human placental estrone/dehydro epiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum J. Steroid Biochem. Mol. Biol. 78 2001 441 450
59. C.T. Noel, M.J. Reed, H.S. Jacobs, and V.H.T. James The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight J. Steroid Biochem. 14 1981 1101
60. H.J. Ruder, D.L. Loriaux, and M.B. Lipsett Estrone sulphate production rate and metabolism in man J. Clin. Invest. 51 1972 1020 1023
61. T. Utsumi, N. Yoshimura, S. Takeuchi, M. Maruta, K. Maeda, and N. Harada Elevated steroid sulfatase expression in breast cancers J. Steroid Biochem. Mol. Biol. 73 2000 141 145
62. Y. Miyoshi, A. Ando, S. Hasegawa, M. Ishitobi, T. Taguchi, Y. Tamaki, and S. Noguchi High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer Clin. Cancer Res. 6 2003 2288 2293
63. V.H.T. James, J.M. McNeill, L.C. Lai, C.J. Newton, M.W. Ghilchik, and M.J. Reed Aromatase activity in normal breast tissues: in vivo and in vitro studies Steroids 50 1987 269 279
64. S.J. Santner, P.D. Feil, and R.J. Santen In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance vs. the aromatase pathway J. Clin. Endocrinol. Metab. 59 1984 29 33
65. B.-L. Nguyen, I. Ferme, G. Chetrite, and J.R. Pasqualini Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells J. Steroid Biochem. Mol. Biol. 46 1993 17 23
66. D.S. Fischer, S.K. Chander, L.W.L. Woo, J.C. Fenton, A. Purohit, M.J. Reed, and B.V.L. Potter Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity J. Steroid Biochem. Mol. Biol. 84 2003 343 349
67. R.H. Peters, W.R. Chao, B. Sato, K. Shigeno, N.T. Zaveri, and M. Tanabe Steroidal oxathiazine inhibitors of estrone sulfatase Steroids 68 2003 97 110
68. S. Ahmed, C.P. Owen, K. James, L. Sampson, and C.K. Patel Review of estrone sulfatase and its inhibitors - an important new target against hormone dependent breast cancer Curr. Med. Chem. 9 2 2002 263 273
69. A. Billich, P. Nussbaumer, and P. Lehr Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors J. Steroid Biochem. Mol. Biol. 73 2000 225 235
70. D. Poirier, L.C. Ciobanu, and R. Maltais Steroid sulfatase inhibitors Exp. Opin. Ther. Patents 9 1999 1083 1099
71. A. Vienonen, H. Syvala, S. Miettinen, P. Tuohimaa, and T. Ylikomi Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines J. Steroid Biochem. Mol. Biol. 80 2002 307 313
72. G.S. Chetrite, H.J. Kloosterboer, and J.R. Pasqualini Effect of Tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells Anticancer Res. 17 1997 135 140
73. G.S. Chetrite, C. Ebert, F. Wright, J.C. Philippe, and J.R. Pasqualini Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines J. Steroid Biochem. Mol. Biol. 70 1999 39 45
74. J.R. Pasqualini, P. Caubel, A.J. Friedman, J.C. Philippe, and G.S. Chetrite Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines: effect on sulfatase activity in comparison to medroxyprogesterone acetate J. Steroid Biochem. Mol. Biol. 84 2003 193 198
75. G.S. Chetrite, C. Ebert, F. Wright, J.-C. Philippe, and J.R. Pasqualini Effect of medrogestone on 17-hydroxysteroid dehydrogenase activity in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines J. Steroid Biochem. Mol. Biol. 68 1999 51 56
76. J.R. Pasqualini, C. Maloche, M. Maroni, and G. Chetrite Effect of the progestagen promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells Anticancer Res. 14 1994 1589 1593
77. G. Chetrite, E. Le Nestour, and J.R. Pasqualini Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020) J. Steroid Biochem. Mol. Biol. 66 1998 295 302
78. G.S. Chetrite, H.J. Kloosterboer, J.C. Philippe, and J.R. Pasqualini Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines Anticancer Res. 19 1999 269 275
79. J. van de Ven, G.H. Donker, M. Sprong, M.A. Blankenstein, and J.H.H. Thijssen Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells J. Steroid Biochem. Mol. Biol. 81 2002 237 247
80. P. Vihko, V. Isomaa, and D. Ghosh Structure and function of 17 beta-hydroxy steroid dehydrogenase type 1 and type 2 Mol. Cell Endocrinol. 17 2001 71 76
81. J. Adamski, and F.J. Jakob A guide to 17 beta-hydroxysteroid dehydrogenases Mol. Cell Endocrinol. 171 2001 1 4
82. H. Peltoketo, V. Luu-The, J. Simard, and J. Adamski 17 Beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes J. Mol. Endocrinol. 23 1999 1 11
83. G. Soderqvist, M. Poutanen, M. Wickman, B. von Schoultz, L. Skoog, and R. Vihko 17 Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception Clin. Endocrinol. Metab. 83 1998 1190 1193
84. M.M. Miettinen, M.V. Mustonen, M.H. Poutanen, V.V. Isomaa, and R.K. Vihko Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression Biochem. J. 314 1996 839 845
85. H. Sasano, T. Suzuki, J. Takeyama, H. Utsunomiya, K. Ito, N. Ariga, and T. Moriya 17-Beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology Oncology 59 S1 2000 5 12
86. V. Speirs, D.S. Walton, M.C. Hall, and S.L. Atkin In vivo and in vitro expression of steroid-converting enzymes in human breast tumors: associations with interleukin-6 Br. J. Cancer 81 1999 690 695
87. V. Speirs, A.R. Green, and S.L. Atkin Activity and gene expression of 17 beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumorous human breast tissue: the role of IL-8 J. Steroid Biochem. Mol. Biol. 67 1998 267 274
88. M. Poutanen, B. Moncharmont, and R. Vihko 17 Beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin Cancer Res. 52 1992 290 294
89. E.F. Adams, N.G. Coldham, and V.H. James Steroidal regulation of oestradiol-17 beta dehydrogenase activity of the human breast cancer cell line MCF-7 J. Endocrinol. 118 1988 149 154
90. N.G. Coldham, and V.H. James A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity Int. J. Cancer 45 1990 174 178
91. M. Poutanen, V. Isomaa, K. Kainulainen, and R. Vihko Progestin induction of 17 beta-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast-cancer cell line Int. J. Cancer 46 1990 897 901
92. M.R. Tremblay, V. Luu-The, G. Leblanc, P. Noel, E. Breton, F. Labrie, and D. Poirier Spironolactone-related inhibitors of type II 17 beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities Bioorg. Med. Chem. 7 1999 1013 1023
93. W.M. Brown, L.E. Metzger, J.P. Barlow, L.A. Hunsaker, L.M. Deck, R.E. Royer, and D.L. Vander Jagt 17-Beta-hydroxysteroid dehydrogenase type 1: computational design of active site inhibitors targeted to the Rossmann fold Chem. Biol. Interact. 143-144 2003 481 491
94. H. Glatt, H. Boeing, C.E. Engelke, L. Ma, A. Kuhlow, U. Pabel, D. Pomplun, W. Teubner, and W. Meinl Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects Mutat. Res. 482 2001 27 40
95. J.L. Falany, N. Macrina, and C.N. Falany Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation Breast Cancer Res. Treat. 74 2002 167 176
96. J.L. Falany, and C.N. Falany Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells Oncol. Res. 9 1997 589 596
97. M. Suiko, Y. Sakakibara, and M.C. Liu Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases Biochem. Biophys. Res. Commun. 267 2000 80 84
98. E.V. Petrotchenko, M.E. Doerflein, Y. Kakuta, L.C. Pedersen, and M. Negishi Substrate gating confers steroid specificity to estrogen sulfotransferase J. Biol. Chem. 274 1999 30019 30022
99. M.H. Kester, S. Bulduk, H. van Toor, D. Tibboel, W. Meinl, H. Glatt, C.N. Falany, M.W. Coughtrie, A.G. Schuur, A. Brouwer, and T.J. Visser Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters J. Clin. Endocrinol. Metab. 87 2002 1142 1150
100. H. Zhang, O. Varlamova, F.M. Vargas, C.N. Falany, and T.S. Leyh Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase J. Biol. Chem. 273 1998 10888 10892
101. G.T. Beatson On the treatment of inoperable carcinoma of the mamma: suggestions for a few methods of treatment, with illustrative cases Lancet 2 1896 104 107
102. R. Raftogianis, C. Creveling, R. Weinshilboum, and J. Weisz Estrogen metabolism by conjugation J. Natl. Cancer Inst. Monogr. 27 2000 113 124
103. J.D. Yager Endogenous estrogensas carcinogens through metabolic activation J. Natl. Cancer Inst. Monogr. 27 2000 95 112
104. A.A. Adjei, and R.M. Weinshilboum Catecholestrogen sulfation: possible role in carcinogenesis Biochem. Biophys. Res. Commun. 292 2002 402 408
105. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 1999 CA Cancer J. Clin. 49 1999 8 31
106. N.K. Wenger Cornary heart disease: an older woman's major health risk Br. Med. J. 315 1997 1085 1090
107. S.A. Beresford, N.S. Weiss, L.F. Voigt, and B. McKnight Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women Lancet 349 1997 458 461
108. K.L. Cushing, N.S. Weiss, L.F. Voigt, B. McKnight, and S.A. Beresford Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens Obstet. Gynecol. 91 1998 35 39
109. J. Botella, E. Duranti, I. Duc, A.M. Cognet, R. Delansorne, and J. Paris Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells J. Steroid Biochem. Mol. Biol. 50 1994 41 47
110. W.H. Catherino, and V.C. Jordan Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity J. Steroid Biochem. Mol. Biol. 55 1995 239 246
111. J. Botella, E. Duranti, V. Viader, I. Duc, R. Delansorne, and J. Paris Lack of estrogenic potential of progesterone- or 19-norprogesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells J. Steroid Biochem. Mol. Biol. 55 1995 77 84